ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,062.00
      -0.10%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.00%
      Bitcoin
      66,819.06
      -0.39%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Timber Pharmaceuticals Inc (TMBR)

      7. Timber Pharmaceuticals Inc (TMBR) News

      TMBR

      Timber Pharmaceuticals (TMBR)

      Timber Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:TMBR
      DateTimeSourceHeadlineSymbolCompany
      11/28/20235:21PMGlobeNewswire Inc.Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE AmericanAMEX:TMBRTimber Pharmaceuticals Inc
      09/18/20234:05PMGlobeNewswire Inc.Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing ComplianceAMEX:TMBRTimber Pharmaceuticals Inc
      08/21/20238:00AMGlobeNewswire Inc.Timber Pharmaceuticals to be Acquired by LEO PharmaAMEX:TMBRTimber Pharmaceuticals Inc
      07/03/20234:05PMGlobeNewswire Inc.Timber Pharmaceuticals Discloses Communication From NYSE AmericanAMEX:TMBRTimber Pharmaceuticals Inc
      06/20/20238:00AMGlobeNewswire Inc.Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
      06/05/20238:00AMGlobeNewswire Inc.Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001AMEX:TMBRTimber Pharmaceuticals Inc
      05/15/20234:15PMGlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
      03/31/20234:28PMGlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
      03/20/20238:00AMGlobeNewswire Inc.Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental DermatologyAMEX:TMBRTimber Pharmaceuticals Inc
      02/24/20238:00AMGlobeNewswire Inc.Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
      12/14/20228:30AMGlobeNewswire Inc.Timber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward OutlookAMEX:TMBRTimber Pharmaceuticals Inc
      12/09/20224:05PMGlobeNewswire Inc.Timber Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsAMEX:TMBRTimber Pharmaceuticals Inc
      11/14/20228:00AMGlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
      11/09/20228:20AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
      11/08/20224:38PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
      11/08/202212:09PMGlobeNewswire Inc.Timber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock SplitAMEX:TMBRTimber Pharmaceuticals Inc
      11/03/20228:42AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
      11/03/20228:22AMGlobeNewswire Inc.Timber Pharmaceuticals Announces Halt of Common Stock Trading  AMEX:TMBRTimber Pharmaceuticals Inc
      10/26/20228:40AMTipRanksAnalysts Are Bullish on These Healthcare Stocks: Biogen (BIIB), Timber Pharmaceuticals (TMBR)AMEX:TMBRTimber Pharmaceuticals Inc
      10/25/20228:31AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
      10/25/20228:00AMGlobeNewswire Inc.Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
      10/03/20224:16PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
      10/03/202210:56AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:TMBRTimber Pharmaceuticals Inc
      10/03/20229:00AMGlobeNewswire Inc.Timber Pharmaceuticals Announces $1.3 Million Registered Direct OfferingAMEX:TMBRTimber Pharmaceuticals Inc
      09/14/20228:00AMGlobeNewswire Inc.Timber Pharmaceuticals Receives Positive Opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
      09/12/20224:43PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
      09/02/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
      08/29/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
      08/29/20224:05PMGlobeNewswire Inc.Timber Pharmaceuticals Announces Notification of NYSE American Continued Listing DeficiencyAMEX:TMBRTimber Pharmaceuticals Inc
      08/29/20228:00AMGlobeNewswire Inc.Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV CongressAMEX:TMBRTimber Pharmaceuticals Inc
       Showing the most relevant articles for your search:AMEX:TMBR

      Your Recent History

      BIT
      Q00422
      Leonteq Securities
      BIT
      SXLB
      Spdr S&p U.s. Materials ...
      Delayed Upgrade Clock